COMMUNIQUÉS West-GlobeNewswire

MoonLake Immunotherapeutics Reports Full Year 2023 Financial Results, Recent Business Highlights and Announces an R&D Day on March 10

29/02/2024 - 14:00

MoonLake Immunotherapeutics Reports Full Year 2023 Financial Results, Recent Business Highlights and Announces an R&D Day on March 10 A successful year including the announcements of positive data from two Phase 2 [...]

ZyVersa Therapeutics Generated Approximately $2.7 Million From Exercise of Warrants Following Excitement Around News That Inflammasome Inhibitors Have Potential to Effectively Treat Obesity

29/02/2024 - 13:57

ZyVersa is developing Inflammasome ASC Inhibitor IC 100, which is designed to inhibit formation of multiple types of inflammasomes, including NLRP3, and their associated ASC specks to attenuate initiation and [...]

Dentsply Sirona Reports Fourth Quarter and Full Year 2023 Results, Provides Full Year 2024 Outlook, Raises Dividend

29/02/2024 - 12:00

FY23 net sales of $3,965 million increased 1.1% , organic sales increased 2.2% FY23 GAAP net income ( loss ) of ($132) million or ($0.62) per share, adjusted EPS of $1.83 Q4 net sales of $1,012 million increased 2.9% , [...]

Medigene Presents at CAR-TCR Summit Europe Showcasing Unique Approach for Development of Differentiated TCR-T Therapies

29/02/2024 - 12:00

Multiple members of management as expert speakers including Prof. Dr. Dolores Schendel, Chief Scientific Officer of Medigene, Dr. Barbara Lösch, Head of Technology & Innovation and Dr. Kirsty Crame, Vice President, [...]

AB Science will host a live webcast on Monday March 4, 2024, from 6.30pm to 7.30pm CET

29/02/2024 - 11:49

PRESS RELEASE AB SCIENCE WILL HOST A LIVE WEBCAST ON MONDAY MARCH 4, 2024 FROM 6.30PM TO 7.30PM CET Paris, 29 February, 2024, 11.30am CET AB Science SA (Euronext – FR0010557264 – AB) will host a live webcast on Monday [...]

AB Science tiendra une conférence virtuelle le lundi 4 mars 2024, de 18h30 à 19h30

29/02/2024 - 11:49

COMMUNIQUE DE PRESSE AB SCIENCE TIENDRA UNE CONFERENCE VIRTUELLE LE LUNDI 4 MARS 2024, DE 18H30 A 19H30 Paris, 29 février 2024, 11h30 AB Science SA (Euronext – FR0010557264 – AB) tiendra une conférence virtuelle le [...]

DONESTA® safety study for menopause completes treatment phase and advances to data management & reporting phase

29/02/2024 - 11:42

DONESTA ® safety study for menopause completes treatment phase and advances to data management & reporting phase Mithra on-track for completion of Phase 3 study for DONESTA ® to treat vasomotor symptoms (VMS) in [...]

Bringing confident diagnosis to more patients at low cost: Philips launches new AI-enabled CT 5300 at #ECR2024

29/02/2024 - 10:00

February 29, 2024 New CT 5300 system provides more accurate and reliable imaging results to better manage increase in complex cardiac cases where precise patient diagnosis is crucial Philips’ latest innovation leverages [...]

RAMSAY SANTE :half-year financial report as at end of December 2023 disposal

29/02/2024 - 09:28

Paris, February 29, 2024 RAMSAY SANTE Half-year Financial Report as at end of December 2023 disposal This document is available on RAMSAY SANTE Internet site : http://www.ramsaysante.fr About Ramsay Santé : Ramsay Santé [...]

RAMSAY SANTE : mise à disposition du rapport financier semestriel au 31 décembre 2023

29/02/2024 - 09:28

Paris, le 29 février 2024 RAMSAY SANTE Mise à disposition du rapport financier semestriel au 31 décembre 2023 Ce document est disponible sur le site internet de RAMSAY SANTE : http://www.ramsaysante.fr A propos de [...]

Verona Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

29/02/2024 - 08:00

PDUFA Target Action Date for ensifentrine of June 26, 2024 Commercialization preparations advance Strong balance sheet supports commercialization and Company's growth Conference call today at 9:00 a.m. EST / 2:00 p.m. [...]

Pharming Group to report fourth quarter and full year 2023 financial results on March 14

29/02/2024 - 08:00

Leiden, The Netherlands, February 29, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary (unaudited) fourth quarter and full year 2023 financial [...]

ONWARD® Medical Awarded 10th Breakthrough Device Designation for Brain-Computer Interface (BCI) from US FDA

29/02/2024 - 07:41

Award gives priority US regulatory review to Company’s ARC-BCI™ System EINDHOVEN, the Netherlands, Feb. 29, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating [...]

argenx Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update

29/02/2024 - 07:00

$374 million in fourth quarter and $1.2 billion in full year global net product sales sBLA for VYVGART® Hytrulo for CIDP accepted for priority review by FDA with PDUFA target action date of June 21, 2024 On track to [...]

IBA signs contract with IAEA for the installation of a Cyclone® KEY in Benin, West Africa

29/02/2024 - 07:00

Contract with IAEA demonstrates Cyclone ® KEY’s accessibility for low- and middle-income countries Louvain-la-Neuve, Belgium, February 29, 2024 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle [...]

IBA signe un contrat avec l’AIEA pour l'installation d'un Cyclone® KEY au Bénin, en Afrique de l'Ouest

29/02/2024 - 07:00

Ce contrat avec l’AIEA démontre l'accessibilité du Cyclone ® KEY pour les pays à revenu faible et intermédiaire Louvain-la-Neuve, Belgique, le 29 février, 2024 – IBA (Ion Beam Applications S.A., EURONEXT), le leader [...]

U.S. CDC Advisory Committee (ACIP) Recommends Use of Valneva’s Single-Dose Chikungunya Vaccine IXCHIQ®

29/02/2024 - 07:00

U.S. CDC Advisory Committee (ACIP) Recommends Use of Valneva’s Single-Dose Chikungunya Vaccine IXCHIQ ® Recommendation for use in travelers and laboratory workers follows U.S. Food and Drug Administration (FDA) approval [...]

Le Comité consultatif sur la vaccination aux États-Unis (ACIP) recommande l’utilisation d’IXCHIQ®, le vaccin à injection unique contre le chikungunya de Valneva

29/02/2024 - 07:00

Le Comité consultatif sur la vaccination aux États-Unis (ACIP) recommande l’utilisation d’IXCHIQ ® , le vaccin à injection unique contre le chikungunya de Valneva La recommandation pour l’utilisation chez les voyageurs [...]

BioSenic S.A. : Information on the total number of voting rights and shares

29/02/2024 - 07:00

PRESS RELEASE – REGULATED INFORMATION Mont-Saint-Guibert, Belgium, 29 February 2024, 7.00 am CEST – BIOSENIC (Euronext Brussels and Paris: BIOS), the clinical-stage company specializing in serious autoimmune and [...]